Gotham Asset Management LLC Sells 5,519 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Gotham Asset Management LLC cut its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 19.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,322 shares of the biotechnology company’s stock after selling 5,519 shares during the period. Gotham Asset Management LLC’s holdings in Axon Enterprise were worth $13,266,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. lifted its position in Axon Enterprise by 3.4% during the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock worth $5,019,886,000 after buying an additional 275,959 shares in the last quarter. Geode Capital Management LLC raised its holdings in Axon Enterprise by 3.7% during the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company’s stock worth $1,095,542,000 after acquiring an additional 65,097 shares in the last quarter. Capital World Investors boosted its position in Axon Enterprise by 86.4% during the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company’s stock valued at $1,079,145,000 after purchasing an additional 841,772 shares during the last quarter. Alliancebernstein L.P. grew its stake in Axon Enterprise by 273.8% in the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company’s stock valued at $659,128,000 after purchasing an additional 812,337 shares in the last quarter. Finally, Norges Bank acquired a new position in shares of Axon Enterprise during the 4th quarter worth approximately $482,081,000. Institutional investors own 79.08% of the company’s stock.

Insider Activity

In other news, Director Jeri Williams sold 307 shares of the company’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the transaction, the chief executive officer now directly owns 3,063,982 shares in the company, valued at $1,657,583,622.18. This trade represents a 0.33 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 4.40% of the company’s stock.

Axon Enterprise Trading Down 0.3 %

Shares of Axon Enterprise stock opened at $684.59 on Friday. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The stock has a market cap of $53.29 billion, a PE ratio of 176.90, a PEG ratio of 5.17 and a beta of 1.24. The firm has a 50-day moving average of $564.50 and a 200-day moving average of $584.84. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The firm had revenue of $603.63 million for the quarter, compared to analyst estimates of $585.67 million. During the same quarter in the prior year, the business posted $1.15 EPS. The business’s revenue was up 31.3% compared to the same quarter last year. As a group, sell-side analysts forecast that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts recently weighed in on AXON shares. Barclays raised their target price on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an “overweight” rating in a research note on Friday. Needham & Company LLC boosted their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a research note on Thursday. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. The Goldman Sachs Group lifted their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Finally, Craig Hallum cut Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $640.91.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.